Cargando…
SAT-493 A Case of Profound Hypothyroidism Secondary to Immune Check Point Inhibitors
Background: The discovery of immune check-point inhibitors (ICI) revolutionized cancer treatment. CTLA-4, anti-PD-1 and anti-PD-L1 monoclonal antibodies have been approved in recent years. However, the advantageous clinical outcomes can also be associated with potentially severe immune related adver...
Autores principales: | Tun, Yin Nwe, Rodriguez, Giovanna, Bahtiyar, Gul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209753/ http://dx.doi.org/10.1210/jendso/bvaa046.694 |
Ejemplares similares
-
SAT-LB82 Myxedema as Presenting Feature of Profound Primary Hypothyroidism in a Toddler
por: Alradadi, Rasha, et al.
Publicado: (2020) -
SAT493 Laser Ablation For Benign Thyroid Nodules: A Way To Treat And Still Preserve The Thyroid
por: Kalara, Niketa, et al.
Publicado: (2023) -
FRI493 Immune Checkpoint Inhibitors: Effects On Thyroid Nodular Disease
por: Maria Bignoli, Daniela Laura, et al.
Publicado: (2023) -
SAT-623 Acute Bradycardia Secondary to Worsening of Hypothyroidism Post-Iodine Contrast
por: Panthi, Sujata, et al.
Publicado: (2019) -
SAT-467 A Case of Pituitary Hyperplasia Secondary to Uncontrolled Primary Hypothyroidism
por: Alhumaidi, Hebah, et al.
Publicado: (2020)